Tags: Chemical Compound, Chemical Substance.

SCH-50911 is a selective GABAB antagonist developed by Schering-Plough Corporation. Its main applications are in pharmacology research but it has been found to quickly and effectively reverse the symptoms of GHB overdose in mice. In one experiment mice were given a lethal dose of GHB (7000 mg/kg) followed by varying doses of SCH-50911.

Loading...

This page contains content from the copyrighted Wikipedia article "SCH-50911"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.